1427677-01-7

Upstream product

• 1410809-82-3 (S)-methyl 2-(4-(((1 R,2R)-2-(acetoxymethyl)cyclopropyl)buta-1,3-diynyl)benzamido)-3-(tert-butoxycarbonylamino)-3-methylbutanoate 
• 1410809-81-2 4-(((1R,2R)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzoic acid 
• 1410809-80-1 methyl 4-(((1 R,2R)-2-(acetoxymethyl)cyclopropyl)buta-1,3-diynyl)benzoate 
• 1410809-79-8 ((1R,2R)-2-(2,2-dibromovinyl)cyclopropyl)methyl acetate 
• 1410809-78-7 ((1R,2R)-2-formylcyclopropyl)methyl acetate 
• 64-19-7 acetic acid 

Downstream Products

• 1410809-36-7 N-((S)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1R,2R)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide 

Relevant academic research and scientific papers

POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE

Polymorphs of N-((S)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1R,2R)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide (Compound I) are provided. Processes for making the same, as well as related compositions and methods, are also disclosed, particularly with regard to the treatment of bacterial infections.